Lung Cancers Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03804580First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational StudiesTreatment
NCT02736513Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain MetastasesTreatment